46
Growth Score in past quarter
pts
Heat Score 46 in past quarter
-23 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
971121
Vincogen specializes in AI-based precision medicine, focusing on personalized healthcare solutions.
- Derhsing Lai: Founder and CEO
About the Company
Vincogen operates in the biotechnology industry, focusing on AI-based precision medicine. The company's flagship technology, VincoAI, is a generative AI designed to predict medical outcomes without a filter module, marking it as a first-of-its-kind Proof-of-Concept (POC) in precision medicine. Vincogen's research and development efforts
are geared towards creating personalized medicine solutions, with a particular emphasis on gastrointestinal diseases and niche healthcare markets. The company's product offerings include smart drug therapies, VincoAI peptide vaccines, and high potency cytokines formulations, all aimed at advancing the field of personalized healthcare and improving patient outcomes.